Senzime AB (publ)

Welcome to Carnegie. Today I have the pleasure to interview Philip Sieber, CEO of Sensime. Very welcome, Philip. Thank you very much. Very nice to have you here. If you could just start with a short introduction of Sensime.

Sensime is a medical device company. We are headquartered in Uppsala. but originated out of long-term research in the US, specifically from Mayo Clinic. And what we do is we developed a system to monitor neuromuscular block and neuromuscular function in the operating room. So we've developed a system that stimulates the muscles of the patient and then in real time gives you the number of how blocked is this patient, how paralyzed is this patient during surgery to make sure you get the right dose of specifically anesthesia drugs and that you are extubated or you can breathe spontaneously again on your own.

And you have had some pretty nice performance looking at the 2023 and this has continued into 2024. Maybe you could summarize what is behind this very, very strong sales growth that you have reported.